Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/17843286.2020.1829252 http://scihub22266oqcxt.onion/10.1080/17843286.2020.1829252 33012274!?!33012274       Acta+Clin+Belg 2022 ; 77 (2): 280-285 Nephropedia Template TP {{tp|p=33012274|t=2022. Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19 |pdf=|usr=}}{{33012274}} gab.com Text Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19 JO: Acta Clin Belg http://www.kidney.de/pget.php?&tw=1&pmid=33012274 #FOAvip OBJECTIVES: COVID-19 predisposes patients to thrombotic disease. The aim of this guidance document is to provide Belgian health-care workers with recommendations on anticoagulation management in COVID-19 positive patients. METHODS: These recommendations were based on current knowledge and a limited level of evidence. RESULTS: We formulated recommendations for the prophylaxis and treatment of COVID-related venous thromboembolism in ambulatory and hospitalised patients, as well as recommendations for the use of antithrombotic drugs in patients with prior indication for anticoagulation who develop COVID-19. CONCLUSIONS: These recommendations represent an easy-to-use practical guidance that can be implemented in every Belgian hospital and be used by primary care physicians and gynaecologists. Of note, they are likely to evolve with increased knowledge of the disease and availability of data from ongoing clinical trials. Twit Text FOAVip Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19 ????Acta Clin Belg http://www.kidney.de/pget.php?&tw=1&pmid=33012274 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33012274 #FOAvip English Wikipedia <ref>{{Cite pmid|33012274}}</ref> Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19 #MMPMID33012274 Vanassche T; Orlando C; Vandenbosch K; Gadisseur A; Hermans C; Jochmans K; Minon JM; Motte S; Peperstraete H; Peters P; Sprynger M; Lancellotti P; Dehaene I; Emonts P; Vandenbriele C; Verhamme P; Oury C Acta Clin Belg 2022[Apr]; 77 (2): 280-285 PMID33012274show ga OBJECTIVES: COVID-19 predisposes patients to thrombotic disease. The aim of this guidance document is to provide Belgian health-care workers with recommendations on anticoagulation management in COVID-19 positive patients. METHODS: These recommendations were based on current knowledge and a limited level of evidence. RESULTS: We formulated recommendations for the prophylaxis and treatment of COVID-related venous thromboembolism in ambulatory and hospitalised patients, as well as recommendations for the use of antithrombotic drugs in patients with prior indication for anticoagulation who develop COVID-19. CONCLUSIONS: These recommendations represent an easy-to-use practical guidance that can be implemented in every Belgian hospital and be used by primary care physicians and gynaecologists. Of note, they are likely to evolve with increased knowledge of the disease and availability of data from ongoing clinical trials. |*COVID-19[MESH] |*Venous Thromboembolism/drug therapy/prevention & control[MESH] |Anticoagulants/therapeutic use[MESH] |Belgium[MESH] |Humans[MESH]Belgian clinical guidance on anticoagulation management in hospitalise(epmc).pdf DeepDyve Pubget Overpricing